Times are displayed in (UTC-05:00) Eastern Time (US & Canada) Change
8/23/2021 | 11:45 AM to 1:30 PM
Incidence and Risk Factors for Covid-related Urgent Medical Visits Among US Patients Diagnosed with COVID-19 in the Outpatient Setting
Background: While most patients are first diagnosed as outpatients, subsequent need and risk factors for COVID-related urgent medical care has not been described.
Objectives: To estimate incidence and identify risk factors for 30-day COVID-related urgent medical visits among patients first presenting with COVID in the outpatient setting.
Methods: We used the Optum® de-identified COVID-19 Electronic Health Record dataset to identify adults’ first COVID diagnosis (dx) or positive (+) SARS-CoV-2 test (first test/diagnosis=index date [ID]) in the outpatient setting (06/01/2020–12/10/2020) among members of an integrated US healthcare delivery network with ≥1 visit <2 years of the ID. Patients with a previous COVID dx or SARS-CoV-2 + test were excluded. Outcome was 30-day COVID-related urgent medical visits defined as urgent care (UC)/emergency room (ER) visits or hospitalizations (H) (COVID dx during encounter), or COVID-related Hs (COVID as primary or admitting dx). Cumulative incidence function was used to estimate 30-day incidence and 95% confidence intervals (CI) of urgent medical visits. Competing risk regression models were used to derive adjusted hazard ratios (aHR) and 95% CIs assessing relationship between demographics, index month, region, comorbidities, pregnancy, first COVID encounter setting (ER/UC vs not), and baseline healthcare resource use (ER/UC, H) with outcomes.
Results: The 30-day incidence of COVID-related ER/UC/H among 206,741 patients (mean age [standard deviation]: 46.7 years [17.8]; 58.8% women; 77.5% White), was 9.4% (95% CI: 9.3%–9.6%) and 3.8% (95% CI: 3.7%–3.9%) for COVID-related H. Incidence of 30-day COVID-related ER/UC/H and H was highest in the oldest patients (≥85 years: 21.9%/13.0%), those with chronic kidney disease (CKD; 22.8%/12.6%), chronic obstructive pulmonary disease (COPD; 21.5%/11.7%), and ER/UC-based diagnosis (20.5%/8.2%). In adjusted models, factors most strongly associated with 30-day UC/ER/H were older age (aHR [95% CI] ≥85 vs 18–34 years: 3.1 [2.9–3.4]), class III obesity (BMI ≥40 vs 18.5–<25 kg/m^2: 1.7 [1.6–1.8]), pregnancy (2.1 [1.9–2.2]), prior H (2.1 [2.1–2.2]), and ER/UC as setting of COVID diagnosis (2.5 [2.4–2.5]). The same risk factors were most strongly associated with COVID-related Hs.
Conclusions: Those at highest risk of an urgent medical visit within 30 days of an outpatient dx or + test were older, had CKD or COPD, and were first diagnosed in the ER/UC. After adjustment, older age, obesity, ER/UC as setting of COVID dx, prior H, and pregnancy remained strongly associated with 30-day urgent medical visits.
Objectives: To estimate incidence and identify risk factors for 30-day COVID-related urgent medical visits among patients first presenting with COVID in the outpatient setting.
Methods: We used the Optum® de-identified COVID-19 Electronic Health Record dataset to identify adults’ first COVID diagnosis (dx) or positive (+) SARS-CoV-2 test (first test/diagnosis=index date [ID]) in the outpatient setting (06/01/2020–12/10/2020) among members of an integrated US healthcare delivery network with ≥1 visit <2 years of the ID. Patients with a previous COVID dx or SARS-CoV-2 + test were excluded. Outcome was 30-day COVID-related urgent medical visits defined as urgent care (UC)/emergency room (ER) visits or hospitalizations (H) (COVID dx during encounter), or COVID-related Hs (COVID as primary or admitting dx). Cumulative incidence function was used to estimate 30-day incidence and 95% confidence intervals (CI) of urgent medical visits. Competing risk regression models were used to derive adjusted hazard ratios (aHR) and 95% CIs assessing relationship between demographics, index month, region, comorbidities, pregnancy, first COVID encounter setting (ER/UC vs not), and baseline healthcare resource use (ER/UC, H) with outcomes.
Results: The 30-day incidence of COVID-related ER/UC/H among 206,741 patients (mean age [standard deviation]: 46.7 years [17.8]; 58.8% women; 77.5% White), was 9.4% (95% CI: 9.3%–9.6%) and 3.8% (95% CI: 3.7%–3.9%) for COVID-related H. Incidence of 30-day COVID-related ER/UC/H and H was highest in the oldest patients (≥85 years: 21.9%/13.0%), those with chronic kidney disease (CKD; 22.8%/12.6%), chronic obstructive pulmonary disease (COPD; 21.5%/11.7%), and ER/UC-based diagnosis (20.5%/8.2%). In adjusted models, factors most strongly associated with 30-day UC/ER/H were older age (aHR [95% CI] ≥85 vs 18–34 years: 3.1 [2.9–3.4]), class III obesity (BMI ≥40 vs 18.5–<25 kg/m^2: 1.7 [1.6–1.8]), pregnancy (2.1 [1.9–2.2]), prior H (2.1 [2.1–2.2]), and ER/UC as setting of COVID diagnosis (2.5 [2.4–2.5]). The same risk factors were most strongly associated with COVID-related Hs.
Conclusions: Those at highest risk of an urgent medical visit within 30 days of an outpatient dx or + test were older, had CKD or COPD, and were first diagnosed in the ER/UC. After adjustment, older age, obesity, ER/UC as setting of COVID dx, prior H, and pregnancy remained strongly associated with 30-day urgent medical visits.
Authors
Speakers
Wenhui Wei
Regeneron Pharmaceuticals, Inc., Tarrytown, NY
Scott Mellis
Regeneron Pharmaceuticals, Inc., Tarrytown, NY
Gregory Geba
Regeneron Pharmaceuticals, Inc., Tarrytown, NY
Sumathi Sivapalasingam
Regeneron Pharmaceuticals, Inc., Tarrytown, NY
Jessica Jalbert
Regeneron Pharmaceuticals
COVID-19 Epidemiology: Risk Factors, Drug Exposures, and Outcomes
Category
General Sessions
Description
Presenting Author
Jessica Jalbert
| Regeneron Pharmaceuticals